Nisoxetine
- Level
- Commodity
- Parent
- 51292000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292015This classification denotes an antidepressant agent with the molecular formula C17H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17NV064B2D, chemically known as benzenepropanamine, gamma-(2-methoxyphenoxy)-n-methyl- but generally known as nisoxetine, which bears US NIH Compound Identifier 4500. European Medicines Agency schedules Nisoxetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09308MIG. The term NISOXETINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). NISOXETINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nisoxetine under HS 29221980 and SITC 51461. As of Q4 2014, NISOXETINE remains the US FDA Preferred Term for this commodity. Nisoxetine bears US NLM identifiers UMLS ID C0068785 and NCI Concept Code C75172. SMILES: O(C(CCNC)c1ccccc1)c1c(OC)cccc1.
Same parent
Under 51292000 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.